OrphAI Therapeutics

OrphAI Therapeutics is a clinical-stage biopharmaceutical company developing novel treatments for rare diseases and cancer using AI-driven drug discovery. The company targets amyotrophic lateral sclerosis (ALS) and has received orphan drug designation in both the US and EU.